Showing 61 - 70 of 311,346
Conducting clinical trials is an extremely complex undertaking in one country let alone one involving multiple countries. In most cases, the trials are conducted in multiple countries due to strategic reasons in order to obtain regulatory approvals for the drug product or device under study....
Persistent link: https://www.econbiz.de/10014190355
pharmaceuticals. The US-led developed countries bloc argued in favour of patents for pharmaceuticals amidst opposition from Brazil … form of patents for pharmaceuticals, the developing countries were able to extract some procedural and substantive …
Persistent link: https://www.econbiz.de/10013393634
Persistent link: https://www.econbiz.de/10015075658
Persistent link: https://www.econbiz.de/10003375191
The purpose of this report is to analyze the impact that the COVID-19 pandemic has had on the vaccine industry from an international perspective. The objective is to learn from the experience and contribute to the design of better tools for future vaccine development and manufacturing, as we...
Persistent link: https://www.econbiz.de/10014637110
professionals, and including real-world approaches and best practice examples, this new title addresses three key areas - small …
Persistent link: https://www.econbiz.de/10012688808
This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...
Persistent link: https://www.econbiz.de/10014637112
Persistent link: https://www.econbiz.de/10003929594
Exclusivity and Access (IDEAS) -- National Laws -- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals …
Persistent link: https://www.econbiz.de/10013447192
Persistent link: https://www.econbiz.de/10003884819